1.4 million AncestryDNA test kits sold in Q4
Consumer DNA database reaches new milestone and surpasses three million participants
LEHI, Utah, Jan. 10, 2017 -- Ancestry, the global leader in family history and consumer genomics, today announced record sales for AncestryDNA kits during the fourth quarter of 2016:
- Sold more than 560,000 AncestryDNA consumer genomics test kits globally over the holiday weekend starting on Black Friday
- Sold 1.4 million kits in the fourth quarter
- Sold 390,000 more kits in Q4 than were sold in all of 2015
The company also announced that AncestryDNA has reached a new milestone as its consumer DNA platform became the first to exceed three million participants, further establishing the company as the leader in the rapidly growing consumer genomics industry.
“Our focus is on helping consumers around the world take advantage of the latest technology and science to help them learn more about themselves, their families and their place in the world,” said Tim Sullivan, Chief Executive Officer of Ancestry. “Right now, what most people want from a DNA kit is the chance to better understand themselves and get some sense of an answer to the question of ‘Who am I?’ That’s a powerful, emotional thing, and as a company we want to make that experience as rich and rewarding as possible.”
Record-breaking DNA kit sales solidify AncestryDNA’s position as the first choice for consumers looking to learn more about themselves by unlocking the secrets contained in their DNA. The company’s DNA products provide consumers with a prediction of their ethnicity breakdown in addition to the largest universe of potential cousin matches currently available, thanks to the millions of people already in the company’s consumer DNA database.
Ancestry’s leadership in both family history and consumer genomics enables the company to provide consumers with a unique experience that is both constantly improving and flexible enough to grow with a consumer’s own interests. As the AncestryDNA database grows, consumers benefit as the network effect enables the company to deliver insights that are not possible to uncover with smaller databases. Consumers who first come to Ancestry through AncestryDNA can easily delve deeper into the discoveries they make by subscribing to family history services and taking advantage of the hundreds of millions digitized records in the company’s databases.
“We’re constantly investing in, researching and developing new ways for people to dive deeper into their personal stories through DNA and family history, and we’re excited to share some incredible new tools with our customers in the new year,” continued Sullivan. “Every day, we are privileged to see the power of the insights we deliver and how they can transform people’s lives for the better. We’re committed to continuing to provide our customers with the best experience and value out there.”
Sullivan will present an overview of company growth and direction at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 beginning at 5:00 PM Pacific Time.
About Ancestry
Ancestry, the global leader in family history and consumer genomics, harnesses the information found in family trees, historical records, and DNA to help people gain a new level of understanding about their lives. Ancestry has more than 2.4 million paying subscribers across its core Ancestry websites and DNA data from more than 3 million people. Since 1996, more than 19 billion records have been added to Ancestry’s databases, and users have created more than 80 million family trees on the Ancestry flagship site and its affiliated international websites. Ancestry offers a suite of family history products and services including AncestryDNA, Archives, AncestryProGenealogists, Newspapers.com and Fold3. AncestryDNA is owned and operated by Ancestry.com DNA, LLC, a subsidiary of Ancestry.com, LLC.
Contact: Media: Brandon Borrman [email protected] (415) 795-6786 Investors: Jon Laudie [email protected] (801) 705-7925


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



